Circulating Tumor DNA Exposure in Peripheral Blood
Status unconfirmed
Conditions studied: Colorectal Cancer, Pancreatic Adenocarcinoma, Gastric Cancer, Hepatocellular Carcinoma, Non-small Cell Lung Cancer, Bladder Cancer, Melanoma, Ovarian Cancer, Adrenocortical Cancer, Breast Cancer, Other Cancer
In brief
This is a prospective, multi-center, blinded feasibility study. The objective of this study is to test the feasibility of the detection of tumor DNA of a variety of tumors in peripheral blood using a novel process for the detection of circulating tumor DNA (ctDNA).
Key facts
- Study ID
- NCT03517332
- Run by
- Quantgene Inc.
- People needed
- 10000
- Starts
- 2015-01-01
- Expected to finish
- 2019-12-31
- Last updated by the study team
- 2018-11-20
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- This study will include subjects that are diagnosed with a malignancy (cohort
- and a negative cohort with subjects that have not been diagnosed with a malignancy (cohort 2).
- Subjects of both cohorts must:
- Be of age ≥ 18
- Provide written consent for study participation
- Subject of cohort 1 must:
- Have a diagnosis of a malignancy in clinical stage 0 to IV including but not limited to: colon or rectal cancer, pancreatic and gastric cancer, hepatocellular carcinoma, non-small cell lung cancer, bladder cancer, melanoma
- Subjects of cohort 2 must:
- Meet the listed matching criteria
You may not qualify if…
- Subjects of cohort 1 must not: Have been treated for above diagnosed malignancy
- Subjects of cohort 2 must not:
- Have been diagnosed/treated for a malignancy previously
Where it is running
- Florida Hospital Celebration Health — Celebration, Florida, United States (enrolling)
- Orlando Health UF Health Cancer Center — Orlando, Florida, United States (enrolling)
- Premier Surgical Oncology — Centerville, Ohio, United States (enrolling)
- Kettering Medical Center — Dayton, Ohio, United States (enrolling)
- University Hospital of Geneva — Geneva, Switzerland (enrolling)
- University of Arizona Cancer Center — Tucson, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.